Hennessey H, Qadura M. J Vasc Surg. 2019 Sep;70(3):1018-1019. doi: 10.1016/j.jvs.2019.05.007. No abstract available. PMID: 31445640
Single Institution Experience with Hybrid Endovascular and Surgical Repairs Involving the Distal Aortic Arch. Gurupatham S, Qadura M, Andrinopoulos T, Naji F, Szalay D. Ann Vasc Surg. 2019 Jun 11. pii: S0890-5096(19)30362-0. doi: 10.1016/j.avsg.2019.03.008. [Epub ahead of print] PMID: 31200065
Meta-analysis of nontumescent-based versus tumescent-based endovenous therapies for patients with great saphenous insufficiency and varicose veins. Harlock JA, Elias F, Qadura M, Dubois L. J Vasc Surg Venous Lymphat Disord. 2018 Nov;6(6):779-787.e6. doi: 10.1016/j.jvsv.2018.05.026. PMID: 30336907
Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching. Murugavel S, Bugyei-Twum A, Matkar PN, Al-Mubarak H, Chen HH, Adam M, Jain S, Narang T, Abdin RM, Qadura M, Connelly KA, Leong-Poi H, Singh KK. Front Pharmacol. 2018 Jul 11;9:737. doi: 10.3389/fphar.2018.00737. eCollection 2018. PMID: 30050438
Optimization of rifampin coating on covered Dacron endovascular stent grafts for infected aortic aneurysms.
Hennessey H, Luckham E, Kayssi A, Wheatcroft MD, Greco E, Al-Omran M, Harlock J, Qadura M.J Vasc Surg.2019 Jan;69(1):242-248.e1. doi:10.1016/j.jvs.2017.10.069. Epub 2018 Mar 1. PMID: 29503005
Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Qadura M, Terenzi DC, Verma S, Al-Omran M, Hess DA. Stem Cells. 2018 Feb;36(2):161-171. doi: 10.1002/stem.2751. Epub 2018 Jan 3. Review. PMID: 29226477
Evaluating the Effectiveness of Internal Iliac Artery Branched Endovascular Stent Grafts. Naji F, Srivatsav V, Qadura M, Harlock J, Andrinopoulos T, Iyer V, Rapanos T. Ann Vasc Surg. 2017 Nov;45:247-252. doi: 10.1016/j.avsg.2017.06.126. Epub 2017 Jul 6. PMID: 28689946
Hybrid repair of symptomatic aberrant right subclavian artery and Kommerell’s diverticulum. Vucemilo I, Harlock JA, Qadura M, Guirgis M, Gowing RN, Tittley JG. Ann Vasc Surg. 2014 Feb;28(2):411-20. doi: 10.1016/j.avsg.2013.04.016. Epub 2013 Nov 5. Review. PMID: 24200134
Mortality and reintervention following elective abdominal aortic aneurysm repair. Qadura M, Pervaiz F, Harlock JA, Al-Azzoni A, Farrokhyar F, Kahnamoui K, Szalay DA, Rapanos T. J Vasc Surg. 2013 Jun;57(6):1676-83, 1683.e1. doi: 10.1016/j.jvs.2013.02.013. Review. PMID: 23719040
Infected aortic stent graft with Propionibacterium acnes. Harlock JA, Qadura M, Lee G, Szalay DA. Vasc Endovascular Surg. 2013 Jul;47(5):394-6. doi: 10.1177/1538574413487262. Epub 2013 Apr 29. PMID: 23632775
Platelet-adenovirus vs. inert particles interaction: effect on aggregation and the role of platelet membrane receptors. Gupalo E, Kuk C, Qadura M, Buriachkovskaia L, Othman M. Platelets. 2013;24(5):383-91. doi: 10.3109/09537104.2012.703792. Epub 2012 Jul 19. PMID: 22812520
Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice. Qadura M, Waters B, Burnett E, Chegeni R, Hough C, Othman M, Lillicrap D. Haemophilia. 2011 Mar;17(2):288-95. doi: 10.1111/j.1365-2516.2010.02397.x. Epub 2010 Nov 23. PMID: 21091850
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice. Qadura M, Waters B, Burnett E, Chegeni R, Bradshaw S, Hough C, Othman M, Lillicrap D. Blood. 2009 Jul 23;114(4):871-80. doi: 10.1182/blood-2008-09-174649. Epub 2009 May 1. PMID: 19411636
Molecular genetic testing of hemostasis and thrombosis in developing countries: achievements, hopes, and challenges. Ozelo MC, Zapata Esp R, Qadura M, Chegeni R, Othman M. Semin Thromb Hemost. 2008 Sep;34(6):569-78. doi: 10.1055/s-0028-1103368. Epub 2008 Nov 28. PMID: 19085656
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells. Qadura M, Othman M, Waters B, Chegeni R, Walker K, Labelle A, Ozelo M, Hough C, Lillicrap D. J Thromb Haemost. 2008 Dec;6(12):2095-104. doi: 10.1111/j.1538-7836.2008.03165.x. Epub 2008 Sep 27. PMID: 18826393
Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response Waters B,Qadura M, Burnett E, Chegeni R, Labelle A, Thompson P, Hough C, Lillicrap D.
Blood. 2009 Jan 1;113(1):193-203. doi: 10.1182/blood-2008-04-151597. Epub 2008 Sep 24. PMID:18815284
